View Cart
Global Information, Inc.
US:
+1-860-674-8796
EU:
+32-2-535-7543
SG:
+65-6223-2436
Home
|
Category
|
Publishers
|
Custom Research
|
E-mail Alert
|
About Us
|
Contact Us
|
Site Map
|
Pharmaceutical
Drug Discovery
Drug Delivery System
Veterinary Medicine
Bone Disease Treatment
Obesity Treatment
Generic Drugs
OTC Drug
Prescription Drugs
Vaccines
Regulation
Cancer
Diabetes
Infection Disease
Mental Disease
Pharmaceutical Companies
Neurodegenerative Disease
View All Categories
Home
>
Category
>
Pharmaceutical
>
Market Research Report
Due Diligence in Life Science Transactions, 2nd Edition
Published by
Drug & Market Development Publications
Published
2007/10
Content info
74 pages
Product code
DM58086
Price
From
US $ 995
US $ 995
PDF by E-mail (Single User License)
How to Order?
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Table of Contents
Chapter 1: Executive Summary
Chapter 2: Introduction
What is Due Diligence?
How to Use this Guide
Chapter 3: Due Diligence and Life Science Businesses
The Role of Due Diligence in Life Science Transactions
Goals for Due Diligence
The Due Diligence Process
External Parties that can be Tapped for Expertise as Needed
Examples of Due Diligence in the Life Sciences
Eli Lilly and Centocor
Important, Common Traps to Avoid
Not Enough Expertise on the Team
Lack of Coordination
Inadequate Confidentiality Coverage
Too Specific/Too General a Request for Information
Relying Entirely on Seller-provided Information
Chapter 4: Investigation Areas
Corporate Information
Corporate Information Summary
Corporate Information Questions
Transaction Rational
Company Structure and Founders
Management / Shareholder Relations
Business Vision
Investor Composition and Relations
Equity Structure
Subsidiaries and Affiliates
Stock Restrictions
Corporate Information Checklist
Financials
Financials Summary
Financials Questions
Financial Statements
Accounting Issues
Profitability and Expenses
Burn Rate and Funding
Extraordinary Financial Events
Liabilities and Debt
Taxes
Financials Checklist
Products and Market
Products and Market Summary
Products and Market Questions
Current Products
Customer Satisfaction
Data on Marketed Products
Competition
Marketing Strategy
Sales Techniques and Channels
Products and Market Checklist
Research and Development
Research and Development Summary
Research and Development Questions
Group Structure and Talent
R&D Strategy
Product Development
R&D Technologies
Bioinformatics
IP and Publications
Research and Development Checklist
Intellectual Property
Intellectual Property Summary
Intellectual Property Questions
Patents and Ownership
Freedom to Operate and Infringement
Patent Coverage
Trade Secrets
Copyrights
IP Processes
Third-Party Agreements
Intellectual Property Checklist
Operations 4-14
Operations Summary
Operations Questions
Suppliers
Manufacturing
Distribution
Information Technology
Asset Valuations
Operations Checklist
Legal and Corporate Issues
Legal and Corporate Issues Summary
Legal and Corporate Issues Questions
Corporate Minutes
Stock Purchase Records
Contracts
Ownership of Assets
Litigation
Permits
Conflicting terms
Antitrust
Legal and Corporate Issues Checklist
Human Resources
Human Resources Summary
Human Resources Questions
Organizational Structure
Executive Background
Executive Teamwork
Executive Compensation
Employees
Human Resources Checklist
Chapter 5: Independent Investigation
Creative Sources of Information
Primary Sources of Information
Internal Primary Information
External Primary Information
Secondary Sources of Information
World Wide Web Precaution
Secondary Source Listing
Company Background
General Databases
Financial Information
Management Information
Life Sciences Industry
Chapter 6: Conclusion
Chapter 7: Appendices
Example Confidential Disclosure Agreement
Example Request for Information (RFI)
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Example Memorializing Memo
Example Due Diligence Report Executive Summary
TABLE OF EXHIBITS
Exhibit 3.1 Life Science Transactions Requiring Due Diligence
Exhibit 3.2 Venture Capital Investments in Various Sectors of the Life Sciences Space
Exhibit 3.3 M&A Activity in Terms of Number of Transactions and Amount Paid
Exhibit 3.4 Due Diligence Steps for a Buyer
Exhibit 3.5 Top 10 Due Diligence Flags for Venture Capitalists
Exhibit 3.6 You Can' t Know Everything
Exhibit 3.7 Due Diligence Issues in Select Recent Life Science Deals
Exhibit 3.8 Beware Royalty Stacking
Exhibit 5.1 Tips for Conducting Primary Interviews
Exhibit 6.1 Possible Results of Due Diligence
Exhibit 7.1 Example SWOT Analysis of a Hypothetical Company
Related Report
Alzheimer disease - new drugs, markets and companies
Cardiovascular Drug Delivery - technologies,markets and companies
Drug Delivery in Cancer - technologies, markets and companies
Drug Delivery in Central Nervous System Diseases - technologies, markets and companies
King Pharmaceuticals Inc.: PharmaVitae Profile
Please inform me when related publications are released
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.